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Abstract
Luminal nutrient sensing by G-protein-coupled receptors (GPCR) expressed on the apical domain of enteroendocrine cells activates intracellular
pathways leading to secretion of gut hormones that control vital physiological processes such as digestion, absorption, food intake and glucose
homeostasis. The taste 1 receptor (T1R) family of GPCR consists of three members: T1R1; T1R2; T1R3. Expression of T1R1, T1R2 and T1R3 at
mRNA and protein levels has been demonstrated in the intestinal tissue of various species. It has been shown that T1R2–T1R3, in association
with G-protein gustducin, is expressed in intestinal K and L endocrine cells, where it acts as the intestinal glucose (sweet) sensor. A number
of studies have demonstrated that activation of T1R2–T1R3 by natural sugars and artificial sweeteners leads to secretion of glucagon-like
peptides 1&2 (GLP-1 and GLP-2) and glucose dependent insulinotropic peptide (GIP). GLP-1 and GIP enhance insulin secretion; GLP-2
increases intestinal growth and glucose absorption. T1R1–T1R3 combination co-expressed on the apical domain of cholecystokinin (CCK)
expressing cells is a luminal sensor for a number of L-amino acids; with amino acid-activation of the receptor eliciting CCK secretion. This article
focuses on the role of the gut-expressed T1R1, T1R2 and T1R3 in intestinal sweet and L-amino acid sensing. The impact of exploiting T1R2–T1R3
as a nutritional target for enhancing intestinal glucose absorption and gut structural maturity in young animals is also highlighted.
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G-protein-coupled receptors (GPCR) represent the largest
family of cell-surface mediators of signal transduction(1).
GPCR have attracted significant attention in terms of continued
identification and characterisation, with recognition that they
are targets for novel drug discovery. With more recent evidence
demonstrating that nutrient sensing in the gastrointestinal tract
is accomplished by a number of GPCR(2), the role of these
receptors as important nutritional targets is becoming evident.
Nutrient-sensing GPCR for a variety of nutrients have been
identified in the intestinal epithelium. They are expressed on
the apical domain of enteroendocrine (sensor) cells of the
gut and are directly activated by nutrients(3–9). Nutrient
sensing initiates a cascade of events involving hormonal and
neural pathways. This culminates in functional responses that
ultimately regulate vital processes such as nutrient digestion
and absorption, food intake, insulin secretion and metabolism.
This brief article focuses on the role of the taste receptor 1
family of GPCR, T1R1, T1R2, and T1R3, in sweet and L-amino
acid sensing, with particular focus on its role in glucose
absorption, glucose homeostasis and satiety. Moreover, the
impact of exploiting the T1R2–T1R3 heterodimer as a
nutritional target for enhancing intestinal glucose (salt and
water) absorption and gut structural maturity in young animals
is highlighted.
Sweet and L-amino acid sensing in the lingual epithelium
The T1R family present in the taste cells of the lingual epithelium
consists of three members: T1R1; T1R2; T1R3(10,11). These
receptors are distantly related to metabotropic glutamate
receptors (mGluR), extracellular Ca2þ-sensing receptor (CaSR)
and g-aminobutyric acid type B receptor(10). Based on electro-
physiological studies, heterologous expression of taste receptor
subunits and behavioural assays of knockout mice, the
heterodimeric combination of T1R2–T1R3 has been shown to
function as a broad-specificity sweet sensor for natural sugars,
sweet proteins and artificial sweeteners, whereas the combi-
nation of T1R1–T1R3 has been identified as a broad-spectrum
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L-amino acid sensor, responsible for mediating the perception
of the savoury ‘umami’ taste of monosodium glutamate(11,12).
Both the T1R2–T1R3 and T1R1–T1R3 heterodimers are
coupled to the heterotrimeric G-protein gustducin to transmit
intracellular signals(13).
In rodents and many other mammalian species, the lingual
epithelium T1R1–T1R3 heterodimer responds to most of the
twenty standard L-amino acids in the millimolar range(12).
However, the T1R1–T1R3 heterodimer is not activated by
L-tryptophan (TRP)(12). The human T1R1–T1R3 complex
functions as a much more specific receptor, responding
selectively to monosodium glutamate (GLUT) and aspartate
(as well as to the GLUT analogue L-AP4)(10,11). A salient feature
of amino acid taste in animals and umami taste in humans is the
synergistic enhancement of potency when GLUTor other amino
acids combinewith themonophosphate esters of inosineor gua-
nosine nucleotides (IMP and GMP)(14–16). Both GLUT and IMP/
GMP bind to adjacent domains on the N-terminal Venus flytrap
module of T1R1(17), while potentiation of intracellular signal
transmission by IMP is mediated through a-gustducin(18).
Gurmarin, a thirty-five-residue polypeptide from the Indian-
originated tree Gymnema sylvestre (Gurmar), can inhibit both
sweet and L-amino acid sensing by binding to the Venus flytrap
domain of T1R3, inhibiting its function(19–24).
Intestinal sweet sensing
Work carried out in many laboratories has demonstrated that
T1R family members and gustducin are co-expressed in enter-
oendocrine cells in a range of species(5,7,24–33), suggesting that
taste-sensing mechanisms exist in the gastrointestinal tract.
It is well established that enteroendocrine L and K cells
secrete glucagon-like peptides (GLP) (1 and 2) and glucose-
dependent insulinotropic peptide (GIP), respectively, on
encountering glucose in the intestinal lumen. GLP-1 and GIP,
known as incretins, enhance insulin secretion, while GLP-2
increases intestinal growth and glucose absorption(34–36). The
infusion of intestinal lumen with the D-isoforms of glucose,
galactose and fructose and non-metabolisable analogues of
glucose, 3-O-methyl-glucose and a-methyl-glucose, causes
the secretion of GIP and GLP-1 in rats, pigs and
humans(37–39). Furthermore, it has been shown that the
T1R2–T1R3 heterodimer together with the a-subunit of
gustducin resides in K and L endocrine cells containing GIP,
GLP-1 and GLP-2, respectively(7,8,30,33).
Functional evidence for the role of the T1R2–T1R3 hetero-
dimer in intestinal glucose (sweet) sensing, inducing GLP-1,
GLP-2 and GIP release, has been provided using endocrine
cell lines, native intestinal tissue explants and knockout mice
deficient in a-gustducin or T1R3(7,24,32,33). The murine
endocrine cell line GLUTag exhibits markedly increased
GLP-1 secretion upon exposure to the artificial sweetener
sucralose; this secretion is blocked by gurmarin, indicating
that sucralose-induced GLP-1 release occurs through the acti-
vation of the T1R2–T1R3 heterodimer(7). Similar results were
obtained for sucralose-induced GLP-1 release in the human L
endocrine cell line NCI-H716, which was blocked either by
RNA interference targeting of a-gustducin or by the human
sweet taste receptor antagonist lactisole(5). Furthermore, the
plasma levels of GLP-1 and GIP following the introduction of
glucose directly into the proximal intestine are reduced in a-
gustducin or T1R3 knockout mice, compared with wild-type
controls(40). Moreover, these knockout mice have abnormal
insulin profile and prolonged postprandial blood glucose
responses in response to luminal glucose(40). Further work car-
ried out by Geraedts et al.(32) has shown that luminal glucose,
fructose or sucralose evoke release of GLP-1 from mouse ileal
explants embedded in an Ussing chamber, and that secretion
of GLP-1 does not occur in tissue explants from T1R3 knockout
mice(32). Moreover, exposure off mouse intestinal explants to
either glucose or sucralose results in the secretion of GLP-1
and GLP-2, in a dose-dependent manner, and that this secretion
is inhibited in the presence of gurmarin, a specific inhibitor of
T1R3(33) (Fig. 1). Notably, the levels of GLP-1 and GLP-2
released by control and glucose-stimulated tissues were similar
to those observed in in vivo studies in rats and human subjects
given glucose orally or maintained as controls(41,42),
supporting the suitability of intestinal tissue explants for such
studies. In these assays, the endocrine cells reside in their
native niche, and it appears that maintaining contacts with
neighbouring cells is important for endocrine cells to retain
their functional viability(43). Collectively, the data suggest that
the sensing of sugars by the T1R2–T1R3 heterodimer coupled
to gustducin expressed in L and K endocrine cells leads to the
release of GLP-1, GLP-2 and GIP.
However, there are reports indicating that sweeteners do
not trigger the release of incretins. Parker et al.(44) have
reported that primary cultures of adult mouse intestine do
not secrete GIP in response to sucralose. This is not surprising,
since they have indicated that these isolated cells do not
express the T1R2–T1R3 heterodimer(44). There are also
reports that oral ingestion or intragastric infusion of artificial
sweeteners does not increase the secretion of incretins in
rats(45) or humans(46). By feeding rats a single concentration
of sweeteners (50 mg or 1 g/kg body weight, depending on
the sweetener), Fujita et al.(45) have concluded that sweeteners
do not acutely induce the release of incretin hormones. Ma
et al.(46) have also reported that 0·4 or 4 mM-sucralose given
by intragastric infusion does not induce the secretion of
incretins. Interestingly, lactisole, which inhibits T1R3 function,
reduces the blood levels of GLP-1 in humans receiving an
intragastric glucose load(47).
Many artificial sweeteners are partly absorbed in the
stomach and subsequently secreted in the urine(48). Therefore,
the lack of response observed by these workers may be due to
the concentration of the sweeteners being below the threshold
level required for activating the candidate receptor and/or the
lack of availability of the sweetener at the distinct target region
of the intestine. Further work is required to unravel these
controversies.
The majority of membrane-bound proteins, including
GPCR, are low-abundance proteins(49–53). In our experience
more sensitive SYBR green assay rather than TaqMan-based
assay and/or increased amounts of template complementary
DNA (up to 250 ng/reaction) are effective in detecting the
expression of T1R family members, having low abundance
Role of taste receptors in gut chemosensing S9
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114513002286
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 10 Jul 2017 at 15:49:03, subject to the Cambridge Core terms of use, available at
mRNA. This is perhaps why one or two laboratories have
failed to detect the expression of T1R1, T1R2, T1R3 and
gustducin in purified primary enteroendocrine cells using
quantitative PCR(44,54,55). Other factors, such as the prevailing
cell isolation conditions or the small proportion of purified
L or K cells expressing taste receptor subunits and gustducin,
have also been proposed to be responsible for the lack of
detection of taste receptor elements in purified L and K
cells(56).
There are some reports proposing that T1R subunits are
expressed in the colon; however, their precise functions require
further investigations. Iwatsuki et al.(57) have demonstrated the
expression of T1R2–LacZ in mouse small and large intestinal
tissues. Geraedts et al.(32) have reported glucose-stimulated
GLP-1 secretion from Ussing chamber-embedded large
intestinal explants of T1R3, but not T1R2, knockout mice.
They have concluded that T1R3-dependent and independent
pathways are involved in the regulation of GLP-1 secretion in
the colon(32).
It should be borne in mind that L cells in the small and large
intestines may have different phenotypes. Furthermore, in
the lumen of the native colonic tissue, there is hardly any
free glucose available. Glucose is rapidly metabolised to
SCFA by colonic microbiota. SCFA induce the release of
GLP-1 via colonic endocrine L-cell GPR43 (FFAR2)(58). There-
fore, studies directed at the sensing of nutrients in the hindgut
must always consider the digestive activity of the microbiota.
Mechanisms underlying intestinal sweet sensing and
glucose transport regulation: application to the
maintenance of gut health in weaning piglets
The major route for the absorption of dietary glucose (and
galactose) from the lumen of the intestine into enterocytes is
via the apical membrane Naþ/glucose cotransporter-1
(SGLT1)(59–62). The absorption of glucose by SGLT1 also
activates salt (NaCl) and water absorption; this is used as the
route for oral rehydration therapy(63). Thus, the regulation of
SGLT1 is essential for the provision of glucose to the body
and avoidance of intestinal malabsorption. A number of
studies(60,61,64 –67) have established that the expression of
intestinal SGLT1 is enhanced in response to a range of monosac-
charides, including non-metabolisable analogues of glucose.
Furthermore, it has been shown that the pathway underlying
monosaccharide-enhanced SGLT1 expression involves a
luminal membrane GPCR glucose sensor(66).
Convincing evidence for the involvement of gut-expressed
T1R2–T1R3 heterodimer and gustducin in intestinal sweet
transduction and SGLT1 regulation has been provided by
studies using mice in which the genes for either a-gustducin
or the sweet receptor subunit, T1R3, had been deleted. The
elimination of sweet transduction in mice in vivo has been
shown to prevent the dietary monosaccharide-induced up-
regulation of SGLT1 expression that is observed in wild-type
mice(7). Furthermore, it has been demonstrated that artificial
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Fig. 1. Glucagon-like peptide (GLP)-1 and GLP-2 secretion, from mouse small intestine in response to glucose or sucralose. Mouse small-intestinal tissue
explants were incubated for 1 h at 378C in incubation media supplemented with: 10 % (w/v) glucose or untreated (controls), in the absence ( ) or presence ( ) of
5mg/ml gurmarin ((a) and (b)); the indicated concentrations of sucralose or untreated (control) in the absence ( ) or presence ( ) of 5mg/ml gurmarin ((c) and (d)).
Data are means, with standard errors represented by vertical bars. Mean value was significantly different from that of the untreated control in the absence of
gurmarin: *P,0·05, **P,0·01, ***P,0·001. † Mean value was significantly different from that for glucose supplementation in the absence of gurmarin
(P,0·05). Mean value was significantly different from that for sucralose supplementation at the same concentration in the absence of gurmarin: ‡P,0·05,
‡‡P,0·01, ‡‡‡P,0·001. Reprinted with permission from Daly et al.(33).
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sweeteners when included in the diet also enhance the
expression of SGLT1(7). In cats (Felidae family) and chickens,
naturally occurring ‘T1R2 knockout’ models, there is a good
correlation between the absence of T1R2 expression and the
inability to increase SGLT1 expression in response to
increased dietary sugars(30,68,69). All together, the data support
the notion that the T1R2–T1R3 heterodimer, in association
with gustducin, senses dietary sugars to regulate the
expression of intestinal SGLT1(7).
To unravel the underlying mechanism by which sugar
activation by the T1R2–T1R3 heterodimer, expressed on the
apical domain of endocrine cells, leads to the up-regulation of
SGLT1 expression in neighbouring enterocytes, the underlying
chemosensing mechanism has been investigated. It is well
established that systemic infusion of GLP-2 enhances
intestinal growth and SGLT1 expression(35,36,70 –72). Moreover,
it has been demonstrated that in vivo vascular infusion of
GLP-2 increases, with a similar magnitude, the maximal rate of
Naþ-dependent glucose transport, Naþ-dependent phlorizin
binding and SGLT1 protein abundance in the intestinal brush
border membrane. This GLP-2 effect was inhibited by brefeldin
A(72), an inhibitor of protein translocation from the trans-Golgi
apparatus to the plasma membrane(73–75), suggesting that
GLP-2, increases the number if SGLT1 protein molecules in
the brush border membrane(72).
As shown in Fig. 1, the exposure of mouse small intestinal
explants to glucose or sucralose evokes the secretion of
GLP-2, in a dose-dependent manner, which is inhibited in
the presence of gurmarin, indicating that glucose/sucralose-
induced GLP-2 release occurs via the activation of the
T1R2–T1R3 heterodimer. Since the GLP-2 receptor is
expressed in enteric neurons(76), and not in absorptive enter-
ocytes, a direct paracrine effect of GLP-2 on the neighbouring
enterocytes is excluded. The knowledge that direct adminis-
tration of GLP-2 to enteric neurons induces a neuronal
response(76,77) and that electric stimulation of enteric neurons
results in the up-regulation of SGLT1 expression, which is
inhibited by nerve blocking agents (our own observation),
implies that the binding of GLP-2 to its receptor in enteric
neurons stimulates a reflex response that results in increased
functional expression of SGLT1 in absorptive enterocytes.
Impact
With an intensive livestock production, a shorter suckling
period increases productivity in terms of numbers of piglets
born. However, early weaning has adverse effects on the
intestinal function of piglets, leading to nutrient malab-
sorption, diarrhoea, malnutrition and dehydration(78–80). A
number of field trials (involving more than 4500 piglets)
have shown that artificial sweeteners, included in piglet
feed, are effective in preventing post-weaning intestinal
disorders, enhancing the growth and well-being of early-
weaned piglets(81). It is notable that despite the increased
palatability of feed containing artificial sweeteners, no steady
increase in feed intake has been observed. However, a
consistent enhancement of feed conversion efficiency (i.e. kg
body mass gained per kg feed intake) has been observed, and
the reason for this, until recently, was unknown. The
understanding of the molecular basis by which artificial
sweeteners enhance gut structural maturity and increase intes-
tinal glucose (salt and water) absorption has led to an effective
utilisation of sweeteners as dietary supplements, routinely
included in the diet of early-weaned piglets to prevent post-
weaning intestinal disorders.
Intestinal sensing of L-amino acids
Protein hydrolysates, peptides and amino acids elicit the
secretion of cholecystokinin (CCK) both in vivo and
in vitro (82–91). CCK plays a variety of roles in digestive
processes, such as slowing of gastric emptying, mediation of
intestinal motility and stimulation of pancreatic and gall
bladder secretions(92–95). It also inhibits food intake in a
manner consistent with a role in satiety(96). Amino acids, in
particular L-phenylalanine (PHE), at physiological concen-
trations (10–50 mmol/l)(97,98) increase plasma CCK levels
and reduce food intake in humans, monkeys, dogs and
rodents(99–102). Leucine (LEU), a branched-chain amino acid,
induces the release of CCK in cats(103).
T1R1 and T1R3 are expressed in mouse intestinal
tissue(24,26,31) and in mouse enteroendocrine STC-1 cells(24).
Immunohistochemistry, using triple immunolabelling, has
demonstrated co-expression of T1R1, T1R3 and CCK in the
same endocrine cell in the mouse proximal intestine(24).
Furthermore, confocal microscopy has shown the expression
of T1R1/T1R3 to be confined to the apical region, with CCK
residing at the basal domain of the same endocrine cells.
Immunohistochemical localisation, using double immuno-
labelling, of mouse proximal intestinal serial sections has
confirmed that T1R1 is not expressed by S, K or L endocrine
cells and that T1R1 expression is confined to CCK-containing
I cells(24). The endocrine cells containing CCK also possess
T1R1, T1R3 and a-gustducin(24).
Functional evidence for the role of the T1R1–T1R3
heterodimer in intestinal L-amino acid sensing and eliciting
CCK release has been provided by using the STC-1 cell line
and mouse proximal intestinal explants. The exposure of
STC-1 cells to the individual L-amino acids PHE, TRP, LEU
and GLUT provokes the secretion of CCK(24). In contrast, the
D-isoforms of these amino acids have no effect, providing
supportive evidence for the specific effect of L-isoforms on
the induction of CCK secretion. Furthermore, the inhibition
of T1R1 expression in STC-1 cells by RNA interference leads
to a significant decrease in CCK secretion in response to
PHE, LEU and GLUT, but not to TRP(24). TRP is a high potency
activator of CaSR(104), but inactive for the T1R1–T1R3
heterodimer(12). IMP, the specific potentiator of the
T1R1–T1R3 heterodimer, significantly enhances the release
of CCK by STC-1 cells in response to PHE, LEU and GLUT,
but not to TRP. Moreover, pre-incubation of STC-1 cells with
gurmarin inhibits the secretion of CCK significantly in
response to PHE, LEU and GLUT, but has no effect on TRP-
induced CCK release(24), collectively indicating that the
T1R1–T1R3 heterodimer functions as a sensor for PHE-,
LEU- and GLUT-induced CCK release in STC-1 cells.
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Mouse proximal intestinal explants secrete CCK in response
to PHE, LEU and GLUT and this secretion is enhanced by the
addition of IMP. However, IMP has no effect on TRP-induced
CCK secretion. Moreover, the release of CCK in response to
PHE, LEU and GLUT, but not to TRP, is inhibited dramatically
by pre-incubation of the tissue with gurmarin(24). Therefore,
the functional properties and cellular location of gut-
expressed T1R1–T1R3 heterodimer support its role as a
luminal sensor for L-amino acid-induced CCK secretion in
mouse proximal intestine.
Using isolated and purified mouse mucosal enhanced green
fluorescent protein-expressing CCK cells, Wang et al.(105) and
Liou et al.(106) have shown that aromatic amino acids L-PHE
and L-TRP stimulate the release of CCK through CaSR(105,106).
We have shown that the addition of a CaSR antagonist,
NPS2143, inhibits PHE-stimulated CCK release partially and
TRP-induced CCK secretion totally in mouse proximal intestinal
tissue explants, with no effect on LEU- or GLUT-induced
CCK secretion (see Fig. 2). The partial and total inhibition of
CaSR-mediated PHE- and TRP-induced CCK secretion is
consistent with data presented by Wang et al.(105), using purified
CCK–enhanced green fluorescent protein cells in the presence
and absence of another CaSR antagonist, Calhex 231(105).
Therefore, it appears that both receptors T1R1–T1R3 and
CaSR are capable of sensing L-PHE. Interestingly, in support
of this, the addition of NPS2143 together with gurmarin totally
inhibits PHE-induced CCK release from mouse proximal intes-
tinal tissue(24) (see Fig. 2). The experimental data suggest that
CaSR acts as an intestinal amino acid receptor specifically
sensing L-aromatic amino acids, while the T1R1–T1R3 hetero-
dimer responds to a number of amino acids provoking CCK
secretion.
Nutrient sensing GPCR are attractive and orally accessible
targets for manipulations by functional foods and supple-
ments. This has applications for maintaining health and
preventing disease.
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are means, with standard errors represented by vertical bars. Mean value was
significantly different from that of the corresponding control (C): *P,0·05,
**P,0·01, ***P,0·001. Mean value was significantly different from that for the
same test agent in the absence of NPS2143 and/or gurmarin: †P,0·05,
††P,0·01. Reprinted with permission from Daly et al.(24).
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